Sartorius: Our Scenario on Why the Shovel Seller in Healthcare Could Start a Growth Phase Thanks to AI!
Reading Time: 2 minutes
Sartorius is a globally leading laboratory and pharmaceutical supplier. The company provides technologies for the development and manufacturing of biopharmaceuticals and supports researchers in optimizing complex laboratory and production processes. Strategy and Outlook: The Best is Yet to Come The management team led by CEO Dr. Michael Grosse looks optimistically at the remainder of the year. Revenue growth is expected to be between 5% and 9%, with the EBITDA margin anticipated to rise above 30%. With innovations like the "Eveo Cell Therapy...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

